Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Accrued Liabilities
Mizuho Medy Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Accrued Liabilities
¥394m
|
CAGR 3-Years
14%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Accrued Liabilities
¥28.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
36%
|
CAGR 10-Years
26%
|
|
|
Olympus Corp
TSE:7733
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sysmex Corp
TSE:6869
|
Accrued Liabilities
¥33B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Accrued Liabilities
¥2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
JEOL Ltd
TSE:6951
|
Accrued Liabilities
¥1.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Accrued Liabilities?
Accrued Liabilities
394m
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Accrued Liabilities amounts to 394m JPY.
What is Mizuho Medy Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
67%
Over the last year, the Accrued Liabilities growth was 33%. The average annual Accrued Liabilities growth rates for Mizuho Medy Co Ltd have been 14% over the past three years , 67% over the past five years .
You don't have any saved screeners yet